https://socictopen.socict.org/files/original/b7aca1e21191192bfaaa12da995b3728.pdf 3b6909143b7acb577bff10936d2a0056 Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Coronavirus Description An account of the resource Dominio científico: Coronavirus Text A resource consisting primarily of words for reading. Examples include books, letters, dissertations, poems, newspapers, articles, archives of mailing lists. Note that facsimiles or images of texts are still of the genre Text. Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Administration of Immunoglobulins in SARS-CoV-2-Positive Patient Is Associated With Fast Clinical and Radiological Healing: Case Report Creator An entity primarily responsible for making the resource Novella Carannante, Novella Carannante, Giuseppe Fiorentino, Giuseppe Fiorentino, Antonio Corcione, Antonio Corcione, Raffaele Di Sarno, Raffaele Di Sarno, Micaela Spatarella, Micaela Spatarella, Nicola Maturo, Nicola Maturo, Fiorentino Fragranza, Fiorentino Fragranza, Pierpaolo Di Micco, Pierpaolo Di Micco Description An account of the resource Polyclonal preparation of IgM as an adjuvant therapy has been reported as a relevant immunomodulant therapy in several infectious diseases, exhibiting, in most cases, improvement of the clinical course. No drug has demonstrated therapeutic efficacy for COVID-19. Immunomodulatory treatment with hydroxychloroquine and biologics as tocilizumab, in fact, has not proven to show satisfactory results in several reports. We therefore treated a selected patient with interstitial multifocal pneumonia, positive to COVID-19, with polyclonal preparation of immunoglobulins as an adjuvant therapy, obtaining in few days clinical remission and improvements in radiological findings. Based on this case report, we suggest that clinical trials are conducted to test the efficacy and safety of polyclonal immunoglobulins for adjunctive therapy of COVID-19. Date A point or period of time associated with an event in the lifecycle of the resource 2020 Subject The topic of the resource covid-19, pneumonia, SARS-CoV-2, Case report, Immunoglobulin, Pentaglobin Identifier An unambiguous reference to the resource within a given context 10.3389/fmed.2020.00388 Source A related resource from which the described resource is derived Epidemiology and Health Publisher An entity responsible for making the resource available Korean Society of Epidemiology Coverage The spatial or temporal topic of the resource, the spatial applicability of the resource, or the jurisdiction under which the resource is relevant Medicine (General)